The challenge The U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR) is a global resource for collaboration providing consultation, training, and innovative scientific solutions in support of FDA's mission to improve public health. Within NCTR, The Division of Bioinformatics and Biostatistics is developing bioinformatics methodologies and standards to support FDA research and [...]

Redx Pharma


The challenge Redx Pharma is a drug discovery and development company focused on creating new drugs for areas of unmet medical need such as cancer and immunology.  As their portfolio rapidly matured, Redx recognised a need for expert safety input as well as ion channel screening data, to develop high quality clinical candidates. The solution [...]

Blueberry Therapeutics


The challenge Blueberry Therapeutics is a dermatology biotech company developing innovative topical drugs for a range of diseases, using a novel ‘nano-delivery’ platform. This technique significantly enhances the penetration of drugs into cells and tissues. Apconix was set the challenge to provide guidance on the most appropriate nonclinical safety studies needed to support the [...]

Bioinformatics and Biostatistics and NCTR/FDA


“It has been a tremendous pleasure to work with Ruth @ApconiX for the past year. Her in-depth knowledge in toxicology in general and drug discovery/development in specific has contributed significantly to my division's research in the area of drug-induced liver injury and in vitro to in vivo extrapolation. I am expecting much great science [...]



"I have had the privilege of knowing Dr. Ruth Roberts for 3 years. I immensely enjoyed discussing the role of ILSI-HESI in the US and in the Europe with Ruth. With her vast experience in the field of Toxicology, especially in ion-channel, she is blessed with innovative thinking in nonclinical toxicology and safety science. [...]